(RTTNews) - Yuhan Corp. (000100.KS, 000105.KS), a South Korean pharmaceutical and chemical manufacturing company, on Wednesday reported a decline in net income despite higher sales in the third quarter of 2026 compared with the previous year.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.